 |
|
|
|||||
AI cloud computing giant CoreWeave announced on Monday it has signed a deal to acquire Core Scientific, a data center provider, in an all-stock deal valued at $9 billion. The news sent share of both companies tumbling in early trading on Monday, with CoreWeave (NASDAQ: CRWV) slightly recovering by midday, down almost 3%, while Core Scientific (NASDAQ:CORZ) remained in the red, down a staggering 16%. However, Core Scientific stock is still up about 25% since the deal was first reported by the Wall Street Journal last month, as noted by Investopedia. The deal, which is expected to close by the fourth quarter of 2025subject to both regulatory approval, and approval from Core Scientific’s stockholderswill enable CoreWeave to bring Core Scientific’s nationwide data center infrastructure in-house, so it can support large-scale artificial intelligence development as it races to compete in the AI boom. “This acquisition accelerates our strategy to deploy AI and HPC workloads at scale,” CoreWeave’s CEO and co-founder Michael Intrator said in a statement. “Verticalizing the ownership of Core Scientifics high-performance data center infrastructure enables CoreWeave to significantly enhance operating efficiency and de-risk our future expansion, solidifying our growth trajectory. Owning this foundational layer of our platform will enhance our performance and expertise as we continue helping customers unleash AIs full potential.” Both companies have a history of working together, and the deal follows a previous merger bid last year, which Core Scientific rejected on the grounds it was too low, per the Journal. The deal is forecast to save CoreWeave some $10 billion in future leasing contract costs from Core Scientific, according to Yahoo Finance. CoreWeave and Core Scientific by the numbers CoreWeave went public this past March in a highly anticipated initial public offering, which CNBC called the biggest venture-backed IPO for a U.S. company since 2021, following a long lapse of tech IPOs. In its March prospectus filing, the company, whose largest customer is Microsoft, reported a net loss of $863 million, with revenue growth of 737% last year to $1.92 billion. It has a market capitalization of $76.73 billion. Core Scientific reported earnings for the first quarter of 2025 totaling $79.53 million in quarterly revenue, which fell short of analyst estimates of $92.04 million, although its earnings per share (EPS) of -$0.10 beat the street’s estimates of -$0.12. It has a market capitalization of $4.46 billion.
Category:
E-Commerce
Isomorphic Labs, the AI-powered drug company spun out of Googles DeepMind, just announced that its getting ready to begin human clinical trials of drugs designed by AI. In an interview with Fortune on July 6, Colin Murdoch, Isomorphic Labs president and Google DeepMinds chief business officer, shared that the company is currently gearing up to start human trials. This milestone will mark the first time that Google DeepMinds breakthrough AI drug discovery system, AlphaFold3, will be put into practice on actual patients. The news comes as tech companies and research institutions are rolling out new applications for AI in medicine at a frantic pace. Early this month, Microsoft released a report claiming that its new AI Diagnostic Orchestrator is around four times more accurate than a human physician when it comes to diagnosing complex issues. On the same day, researchers at Northwestern Medicine published a study on a new AI-powered device that may revolutionize cancer screening. Now, heres what to know about Isomorphic Labs’ next major step in AI-powered drug development: What is Isomorphic Labs? Isomorphic Labs is a London-based drug developer thats owned and operated by Alphabet Inc. The company was founded in 2021 as an offshoot from DeepMind, Googles multidisciplinary AI research arm. In multiple interviews, Isomorphic Labs executives have explained the companys intimidating goal: to eventually solve all diseases using AI. This isnt about developing therapeutics for a particular indication or a particular target, Max Jaderberg, chief AI officer at Isomorphic Labs, explained in an interview this April. Its really thinking about, how do we create a really general drug design engine with AIsomething that we can apply to not just a single target, or even a single modality, but we can apply this again and again across any different disease area? What is AlphaFold AI? The key unlock driving Isomorphic Labs expansive goal is its trailblazing AlphaFold AI system, a discovery that earned a Nobel Prize in chemistry last October. The most recent iteration of the technology, AlphaFold3, can predict proteins complex structures, as well as modeling how certain proteins might interact with other molecules, like DNA and drugs. These insights can essentially give researchers a supercharged headstart on drug development. DeepMind CEO Demis Hassabis explained the tech in a conference call last May: You imagine that AlphaFold gives you the structure of a protein youre interested in, in a particular disease, let’s say, and with these new capabilities we can now design a compound or ligand (a ‘chemical messenger‘) that will bind to a specific place . . . on the surface of the protein, once you understand the structure of it, and we can predict how strong the binding affinity will be, Hassabis said. Its a critical step if you want to design drugs. Currently, AlphaFold serves as an AI-powered first step in drug development. After the AlphaFold3 system models a potential interaction, researchers then need to use other AI models to predict factors like toxicity and interactions with other drugs. Then, to actually commercialize a new drug, it needs to be tested in wet lab experiments, followed by human clinical trials. Whats happening now? Now, that human clinical trial step is finally in sight. According to Murdoch, Isomorphic Labs team is currently collaborating with AI to design drugs for cancer, and is already staffing up for its first human clinical trials. One day we hope to be able to saywell, heres a disease, and then click a button and out pops the design for a drug to address that disease, all powered by these amazing AI tools, Murdoch told Fortune. Isomorphic Labs did not immediately respond to Fast Companys request for comment on what form of cancer its first trial drugs will be designed to target.
Category:
E-Commerce
Journey with me back to the good old days, if you will. There was a time that, when youd buy a gadget, itd come with a sometimes verbose but often helpful instruction manual. Not a quick start guide: an honest-to-goodness manual that you could pore through. Your patience and attention to detail would be rewarded, as youd learn tons of helpful tips and tricks that youd almost certainly never stumble upon on your own. Those days are gone. Im not entirely sure when this became a thing but I do recall opening an Apple gadget many years ago and wondering if theyd forgotten to include the manual. Anyway. The point is that Ive had my Pixel 9 for months and months, and I finally got around to digging into its many features and functionality. And, indeed, I found some stuff that was unexpected, and pretty great. Quick Tap Shortcuts Well start with my favorite. Dive into Settings > System > Gestures > Quick tap to start actions and prepare to be mildly surprised. You can set it to take a screenshot, summon the Google Assistant, pause or resume media, or even open a specific app. Once youve made your choice, thwap-thwap the back of your phone with your index finger while youre holding it and see what happens. I know, right?! Notification History Ever dismiss a notification in a fit of overwhelmed rage and then realize it was actually important? Your Pixel has a built-in safety net. The “Notification History” feature keeps a log of all your recent notifications, even the ones you swiped away in a moment of haste. To find it, go to Settings > Notifications > Notification History and make sure it’s turned on. You’ll never miss a crucial alert again. Hold For Me OK, this one isn’t entirely unknown, but if you havent experienced its glorious potential, youre missing out. If youre on a call and you find yourself trapped in the endless purgatory of hold music, keep an eye out for the “Hold for me” button. Tap it, and your Pixel will listen for a real human voice on the other end. When someone actually picks up, you’ll get a notification to jump back onto the call. It’s not foolproof, but when it works, it feels like a tiny miracle. Long Screenshots Taking a screenshot of a long web page or conversation used to be a multistep dance of multiple captures. But your Pixel has a hidden superpower: scrolling screenshots. Take a regular screenshot (power + volume down). Instead of just disappearing, a little “Capture more” buttonan icon with up and down arrowswill often appear at the bottom. Tap it, and you can drag the borders to capture the entire scrollable content. It’s great for saving entire articles or those lengthy text message threads where youre trying to win an argument with someone by using their past words against them. So much drama. Adaptive Vibration Tucked away in Settings > Sound & vibration > Adaptive vibration, you’ll find a feature that subtly adjusts your phone’s vibration intensity based on your surroundings. In a quiet room, your notifications might be softer. In a noisy environment or if your phones in your pocket, they’ll intelligently boost themselves so you don’t miss crucial calls or messages. It’s not a night-and-day difference, but it’s one of those subtle Pixel touches that makes living with the phone just a little bit nicer.
Category:
E-Commerce
All news |
||||||||||||||||||
|
||||||||||||||||||